IDEXX Laboratories Joins the NASDAQ-100 Index

Monday, March 20, 2017 Drug News
Email Print This Page Comment
Font : A-A+

WESTBROOK, Maine, March 20, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX) announced that it joined the NASDAQ-100

Index® (Nasdaq: NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE), and the NASDAQ-100 Ex Technology Index (Nasdaq: NDXX) prior to market open today.

"We're very pleased that IDEXX is included in the NASDAQ-100 Index, alongside

an impressive group of growth-oriented, domestic and international companies, who are innovators of the modern economy," said Jonathan Ayers, Chairman and Chief Executive Officer of IDEXX Laboratories. "Following our inclusion in the S&P 500 earlier this year, becoming a part of the NASDAQ-100 is further acknowledgment of the tremendous growth our company has achieved through innovation focused on pet healthcare technology."

Launched in January 1985, the NASDAQ-100 Index (NDX) includes many category-defining companies that are on the forefront of innovation in their respective industries, and represents the largest non-financial domestic and international securities listed on The Nasdaq Stock Market based on market capitalization. Since its inception, NDX has become the world's preeminent large-cap growth index, with the aggregate market capitalization of the component companies standing at over $6 trillion and more than $50 billion of investments in exchange traded products tied to the index.

For more IDEXX corporate information, visit: www.idexx.com/investors

About IDEXX Laboratories  IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing livestock and poultry diagnostic tests and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 7,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.

Contact: 

Investor Relations:   Kerry Bennett      1-207-556-8155

Media:   Robin Woodcock  1-617-429-6153

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/idexx-laboratories-joins-the-nasdaq-100-index-300425641.html

SOURCE IDEXX Laboratories, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook